Search for Abstracts Find by Title, Author or Description Year Abstracts - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first B01 – Immune Checkpoint Markers in Pulmonary Large Cell Neuroendocrine Carcinomas Published in 2017 Listed under Basic Science Download Abdel Karim Abstract ID: 300 B02 – The HNV Pancreatic Neuroendocrine Tumor Model Published in 2017 Listed under Basic Science, Poster Download Chamberlain Abstract ID: 273 pdf Download Poster (9.58 MB) B03 – Potentiating mTOR’s Antineoplastic Effects with Rovalpituzumab Tesirate in Neuroendocrine Tumors Published in 2017 Listed under Basic Science Download Chauhan Abstract ID: 251 B04 – Oncogenic Signaling in the PNETs of Multiple Endocrine Neoplasia Type 1 is Epigenetically Regulated by the LncRNA Meg3 Published in 2017 Listed under Basic Science Download Iyer Abstract ID: 225 B05 – Developing Model Systems of Neuroendocrine Tumors: Cell Lines and Patient-Derived Xenograft (PDX) Tumors Published in 2017 Listed under Basic Science Download Kaemmer Abstract ID: 276 B06 – Gene Expression Changes in Small Bowel Neuroendocrine Tumors Associated with Progression to Metastases Published in 2017 Listed under Basic Science, Poster Download Keck Abstract ID: 210 pdf Download Poster (1020 KB) B07 – Transcriptional Alterations in Hereditary and Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors According to Genotype Published in 2017 Listed under Basic Science Download Keutgen Abstract ID: 207 B08 – Somatostatin Receptor Imaging and Therapy in MEN1-Driven Murine Pancreatic Neuroendocrine Tumors Published in 2017 Listed under Basic Science Download Li Abstract ID: 301 B09 – Molecular Imaging of High-Grade Neuroendocrine Tumors Using Novel Peptide-Receptor Targeted Radiopharmaceuticals Published in 2017 Listed under Basic Science Download Liu Abstract ID: 267 B10 – Enriched Immune Cell Activities in the Tumor Microenviroments of Metastatic Pancreatic Neuroendocrine Tumors Published in 2017 Listed under Basic Science Download Moore Abstract ID: 302 B11 – Efficacy of mTOR Inhibition in Pulmonary Large Cell Neuroendocrine Carcinomas (LCNEC) Published in 2017 Listed under Basic Science Download Orr-Asman Abstract ID: 278 B12 – Evaluating Transcription Factor Networks as Targets for the Treatment of Neuroendocrine Tumors Published in 2017 Listed under Basic Science Download Pozo Abstract ID: 269 B13 – Isolation and Characterization of Small Bowel Neuroendocrine Tumor Cell Line Published in 2017 Listed under Basic Science Download Rodman Abstract ID: 310 B14 – ONECUT2: A Targetable Master Regulator of Progression to Neuroendocrine Differentiation from Prostate Adenocarcinoma Published in 2017 Listed under Basic Science Download Rotinen Abstract ID: 272 B15 – Sensitizing Hypoxic Small Cell Lung Cancer Cells to Radiation and Hydrogen Peroxide-Producing Agents Using CuATSM Published in 2017 Listed under Basic Science Download Sciegienka Abstract ID: 282 B16 – RABL6A-Dependent Regulation of c-Myc Expression and Activity is Essential for Cell Cycle Progression and Survival of Pancreatic Neuroendocrine Tumor Cells Published in 2017 Listed under Basic Science, Poster Download Abstract ID: 298 Author: Sheehy pdf Download Poster (1.26 MB) B17 – A New Critical Regulator of Akt-mTOR Signaling in Pancreatic Neuroendocrine Tumor Cells Published in 2017 Listed under Basic Science, Poster Download Umesalma Abstract ID: 289 pdf Download Poster (1.15 MB) B18 – Testicular Receptor-4 (TR4): Novel Predictive Biomarker for Disease Related Survival in pNETs Published in 2017 Listed under Basic Science Download Zhang Abstract ID: 304 B19 – DAXX Mutation is Associated with Shorter Hepatic Progression Free Survival After Hepatic Artery Embolization of Neuroendocrine Liver Metastases Published in 2017 Listed under Basic Science Download Ziv Abstract ID: 281 B20 – Immune Checkpoint Inhibitors in Progressive Neuroendocrine Tumors Published in 2017 Listed under Applied Basic Science, Basic Science Download Chauhan Abstract ID: 254 B21 – Role of 92 Gene Cancer Classifier Assay in Neuroendocrine Tumor of Unknown Primary Published in 2017 Listed under Applied Basic Science, Basic Science Download Chauhan Abstract ID: 257 B22 – Molecular Classification of Neuroendocrine Tumors: Clinical Experience with the 92-gene Assay in >24,000 Cases Published in 2017 Listed under Applied Basic Science, Basic Science, Poster Download Hendifar Abstract ID: 224 pdf Download Poster (532 KB) B23 – Diagnostic Utility of SATB2 in Determining the Site of Origin of Well-Differentiated Neuroendocrine Tumors Published in 2017 Listed under Applied Basic Science, Basic Science Download Mohanty Abstract ID: 305 B24 – Activation of Alternative Lengthening of Telomeres (ALT) in Primary Pancreatic Neuroendocrine Tumors Serves as Both a Prognostic Biomarker and Potential Therapeutic Target Published in 2017 Listed under Applied Basic Science, Basic Science Download Rizzo Abstract ID: 233 C01 – Preliminary Safety and Efficacy of Rovalpituzumab Tesirine in Patients with Delta-Like Protein 3-Expressing Advanced Solid Tumors Published in 2017 Listed under Clinical, Poster Download Aggarwal Abstract ID: 229 pdf Download Poster (795 KB) C02 – Outcomes of Locoregional Treatment for Unifocal Progression in Widespread Metastatic Gastroenteropancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical, Poster Download Al-Toubah Abstract ID: 241 pdf Download Poster (450 KB) C03 – Systematic Literature Review of Octreotide's Antitumor Effects in Neuroendocrine Tumors Published in 2017 Listed under Clinical, Poster Download Barrows Abstract ID: 221 pdf Download Poster (233 KB) C04 – Phase II Trial of Cabozantinib in Patients with Carcinoid and Pancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Chan Abstract ID: 290 C05 – Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study Published in 2017 Listed under Clinical, Poster Download Dillon Abstract ID: 255 pdf Download Poster (728 KB) C06 – An Exploratory Patient Centric Analysis of the ELECT Trial: A Phase 3 Study of Efficacy and Safety of Lanreotide Autogel/Depot (LAN) Treatment for Patients (pts) with Carcinoid Syndrome (CS) Published in 2017 Listed under Clinical Download Duchateau Abstract ID: 222 C07 – 5-Hydroxyindoleacetic Acid (5-HIAA) and Chromogranin A (CgA) as Biomarkers Secreted by Neuroendocrine Tumors (NETs): a Pooled Analysis of the ELECT and CLARINET Studies Published in 2017 Listed under Clinical Download Fisher, Jr Abstract ID: 232 C08 – Phase I, Open-label, Dose-Escalation Study of SNX-5422 Plus Everolimus in Neuroendocrine Tumors (NETs) Published in 2017 Listed under Clinical, Poster Download Gutierrez Abstract ID: 249 pdf Download Poster (289 KB) C09 – Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs: Analysis of the Completed TELESTAR Extension Period Published in 2017 Listed under Clinical, Poster Download Hörsch Abstract ID: 214 pdf Download Poster (724 KB) C10 – Predictors of Somatostatin Analogs (SSA) Dose Escalations (DEs) Above Recommended Dosing Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Treated at a Tertiary Referral Center Published in 2017 Listed under Clinical, Poster Download Jalbert Abstract ID: 277 pdf Download Poster (655 KB) C11 – Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease Published in 2017 Listed under Clinical, Poster Download Lapuerta Abstract ID: 212 pdf Download Poster (263 KB) C12 – Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of DP1038, an Intranasal Formulation of Octreotide Acetate, in Healthy Volunteers Published in 2017 Listed under Clinical, Poster Download Lavisetti Abstract ID: 204 pdf Download Poster (758 KB) C13 – Use of Somatostatin Analog Therapy in Patients with Advanced Pheochromocytoma/Paraganglioma and Somatostatin-Receptor Avid Disease Published in 2017 Listed under Clinical, Poster Download Narayan Abstract ID: 228 pdf (727 KB) pdf Download Poster (1.64 MB) C14 – Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial Published in 2017 Listed under Clinical, Poster Download Pavel Abstract ID: 213 pdf Download Poster (727 KB) C15 – Safety and Tolerability of Lanreotide Autogel/Depot in Patients with Neuroendocrine Tumors: Pooled Analysis of Clinical Studies Published in 2017 Listed under Clinical Download Phan Abstract ID: 226 C16 – Elevated Levels of 5-HIAA and CgA in Patients with Pancreatic Neuroendocrine Tumors (PanNETs): Analyses from the CLARINET Study Published in 2017 Listed under Clinical Download Phan Abstract ID: 226 C17 – Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors (NETs) Previously Responsive to Octreotide: Subanalysis of Patient-Reported Symptoms From the Phase 3 ELECT Study Published in 2017 Listed under Clinical Download Pommier Abstract ID: 223 C18 – Pharmacist-Led Development of an Adverse Event (AE) Management Algorithm for the Proactive Monitoring of Patients with Neuroendocrine Tumours (NETs) on Everolimus Published in 2017 Listed under Clinical Download Thawer Abstract ID: 299 C19 – Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome Published in 2017 Listed under Clinical, Poster Download Weickert Abstract ID: 253 pdf Download Poster (727 KB) C20 – Impact of Adjuvant Chemotherapy in Non-Metastatic Node Positive Bronchial Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Westin Abstract ID: 236 C21 – Change in Patient-Reported Symptom Control in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot Published in 2017 Listed under Clinical Download Wolin Abstract ID: 238 C22 – Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: the CLARINET Extension Study Published in 2017 Listed under Clinical, Poster Download Wolin Abstract ID: 262 pdf Download Poster (842 KB) C23 – The Predictive Quotient Index Comprising Gene Cluster Analysis and Grading is Specifically Predictive of PRRT Efficacy Published in 2017 Listed under Clinical Download Bodei Abstract ID: 287 C24 – Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors Published in 2017 Listed under Clinical, Poster Download Chan Abstract ID: 256 pdf (381 KB) pdf Download Poster (381 KB) C25 – MIBG Avidity and Progression-Free Survival in Patients with Metastatic Pheochromocytoma are not Dependent on Germline SDHx Mutation Status Published in 2017 Listed under Clinical Download Fishbein Abstract ID: 261 C26 – Education and Preparation for Nuclear Medicine Procedures in Neuroendocrine Tumor Patients Published in 2017 Listed under Clinical, Poster Download Hedrick Abstract ID: 279 pdf Download Poster (1.06 MB) C27 – Synthesis and Characterization of a 68Ga/NIR Labeled Peptide for Somatostatin Receptor Targeting Published in 2017 Listed under Clinical, Poster Download Hernandez-Vargas Abstract ID: 237 pdf Download Poster (1010 KB) C28 – AZEDRA® (iobenguane I 131) in Patients with Malignant and/or Recurrent Pheochromocytoma/ Paraganglioma (PPGL): Final Results of a Multi-Center, Open-Label, Pivotal Phase 2b Study Published in 2017 Listed under Clinical Download Jiminez Abstract ID: 240 C29 – Safety and Accuracy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Children and Young Adults with Solid Tumors Published in 2017 Listed under Clinical Download O'Dorisio Abstract ID: 303 C30 – Potential for Increasing Tumor Uptake of Radiolabeled MIBG and/or DOTATOC in Patients with Mid-Gut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Published in 2017 Listed under Clinical, Poster Download Pollard Abstract ID: 209 pdf Download Poster (518 KB) C31 – Theranostic Trial of Well Differentiated Neuroendocrine Tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201 Published in 2017 Listed under Clinical Download Reidy-Lagunes Abstract ID: 263 C32 – Feasibility & Safety of Integrated CapTemY90 for Liver-Dominant G2 NETS Published in 2017 Listed under Clinical, Poster Download Soulen Abstract ID: 227 pdf Download Poster (869 KB) C33 – QOL Improvements in NETTER-1 Phase III Trial in Patients with Progressive Midgut Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Strosberg Abstract ID: 205 C34 – Computerized Mutation Prediction Models May be Used to Determine VHL-Associated PNETs Aggressiveness Published in 2017 Listed under Clinical Download Tirosh Abstract ID: 247 C35 – Potential Reduction in Radiation Exposure and in Risk for Malignancy by Using VHL Genotype-Directed Protocol for the Surveillance of PNETs in Patients with Von Hippel-Lindau Disease Published in 2017 Listed under Clinical Download Tirosh Abstract ID: 248 C36 – PFS and OS After Salvage Peptide Receptor Radionuclide Therapy (PRRT) with 177-Lu[Dota°,Tyr³]octreotate in Patients with GastroEnteroPancreatic or Bronchial NeuroEndocrine Tumours (GEP-NETs) – The Rotterdam Cohort Published in 2017 Listed under Clinical Download van der Zwan Abstract ID: 284 C37 – Trans-Anal Minimally Invasive Surgery (TAMIS) for Completion Excision of Localized Well-Differentiated Rectal Neuroendocrine Tumours Published in 2017 Listed under Clinical, Poster Download Chan Abstract ID: 274 pdf Download Poster (545 KB) C38 – Changes in Catecholamine and Metanephrine Levels and 24–Hour Ambulatory Blood Pressure Parameters Before and After Catecholamine-Secreting Neuroendocrine Tumor Resection Published in 2017 Listed under Clinical, Poster Download Cohen MD, MSCE Abstract ID: 246 pdf Download Poster (294 KB) C39 – RNA based In Situ Hybridization for Polyoma Virus is Helpful in Differentiating Merkel Cell Carcinoma from Other High Grade Neuroendocrine Carcinomas Published in 2017 Listed under Clinical Download Dhall Abstract ID: 307 C40 – The Clinical Utility of Blood Neuroendocrine Gene Transcript Measurement in Defining Surgical Resection and Residual Disease in Bronchopulmonary Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Filosso Abstract ID: 297 C41 – Predictive Rates of Survival Based on Ki-67 and Chemotherapy Regimens in Patients with High Grade (HG) Neuroendocrine Tumors (NETs) Published in 2017 Listed under Clinical, Poster Download Hall-Thomas Abstract ID: 308 pdf Download Poster (183 KB) C42 – Peri-Procedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases Published in 2017 Listed under Clinical, Poster Download Kwon Abstract ID: 291 pdf Download Poster (815 KB) C43 – A Minimally Invasive Approach for the Surgical Management of Small Intestine Neuroendocrine Tumors (SI-NETs) Published in 2017 Listed under Clinical Download Mahuron Abstract ID: 252 C44 – Chromogranin A is an Inadequate Circulating Biomarker for Bronchopulmonary Neuroendocrine Neoplasia Management Published in 2017 Listed under Clinical Download Malczewska Abstract ID: 292 C45 – Meta-Analysis with Critical Appraisal of miRNA as a Biomarker in Gastroenteropancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Malczewska Abstract ID: 293 C46 – The Failure of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Meta-Analysis Published in 2017 Listed under Clinical Download Malczewska Abstract ID: 294 C47 – Regional Lymph Node Involvement and Outcomes in Appendiceal Neuroendocrine Tumors: A SEER Database Analysis Published in 2017 Listed under Clinical, Poster Download Mehrvarz-Sarshekeh Abstract ID: 203 pdf Download Poster (836 KB) C48 – Impact of Ki67 Re-Assessment at Time of Disease Progression in Patients with Pancreatic Neuroendocrine Neoplasms Published in 2017 Listed under Clinical Download Partelli Abstract ID: 260 C49 – Tumor Size Correlates with Grading in Nonfunctioning Pancreatic Neuroendocrine Tumors and is Not Age-Dependent Published in 2017 Listed under Clinical Download Partelli Abstract ID: 268 C50 – Number of Positive Nodes Accurately Predicts Recurrence after Pancreaticoduodenectomy for Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Partelli Abstract ID: 270 C51 – Relevance of Serum Chromogranin A as Diagnostic and Prognostic Marker for Well-Differentiated Pancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Pulvirenti Abstract ID: 265 C52 – Nonfunctional Pancreatic Neuroendocrine Tumors: A Retrospective Review and Early Detection Facilitated by EUS and Novel CORE Biopsy Techniques Published in 2017 Listed under Clinical, Poster Download Sharma Abstract ID: 220 pdf Download Poster (556 KB) C53 – The Effects of Peritoneal Carcinomatosis on the Prognosis of Patients with Advanced Midgut Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Wang Abstract ID: 259 C54 – Lobectomy with Mediastinal Nodal Dissection vs. Partial Lobectomy in Patients with Bronchial Carcinoid Tumors Published in 2017 Listed under Clinical Download Westin Abstract ID: 235 C55 – Does Plasma Neurokinin A Predict Survival in Well-Differentiated Neuroendocrine Tumors (NETs) of the Small Bowel? Published in 2017 Listed under Clinical, Poster Download Woltering, MD, FACS Abstract ID: 239 pdf Download Poster (76 KB) C56 – Neuroendocrine Proliferations in Inflammatory Bowel Disease Published in 2017 Listed under Clinical, Poster Download Wong Abstract ID: 306 pdf Download Poster (29.70 MB) C57 – Assessment of Disease Aggression in Cystic Pancreatic NET: a CT and Pathology Correlation Study Published in 2017 Listed under Clinical Download Yano Abstract ID: 202 C58 – Chronic use of Long-acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in patients with Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): An Under-recognized Adverse Effect Published in 2017 Listed under Clinical, Poster Download Saif pdf Download Poster (1.49 MB) O01 – Integrating Patient Reported Outcomes (PROs) in Neuroendocrine Tumors (NETs) Care: An Assessment of Neuropsychological and Quality of Life Screening Tools Published in 2017 Listed under Other Download Hallet Abstract ID: 230 O02 – The Distal Predilection of Small Bowel Neuroendocrine Tumors Published in 2017 Listed under Other, Poster Download Keck Abstract ID: 211 pdf Download Poster (1.01 MB) O03 – Blood Neuroendocrine Transcript Analysis for the Diagnosis and Clinical Status Assessment of Bronchopulmonary Neuroendocrine Tumors Published in 2017 Listed under Other Download Modlin Abstract ID: 296 O04 – Pancreatic Neuroendocrine Tumors: CT Enhancement, but not Histologic Grade, Correlates with Tumor Aggression Published in 2017 Listed under Other Download Yano Abstract ID: 201 P01 – Predictive Factors of Carcinoid Syndrome (CS) Among Patients with Gastrointestinal Neuroendocrine Tumors (GI NETs) Published in 2017 Listed under P, Poster Download Cai Abstract ID: 217 pdf Download Poster (534 KB) P02 – A Novel Form of Familial Multiple Carcinoid Tumors Affecting the Small Intestine, Lung, Pancreas and Colon Published in 2017 Listed under P Download Chitsaz Abstract ID: 286 P03 – Neuroendocrine Tumors and Obesity: A Targeted Literature Review Published in 2017 Listed under P Download Colby Abstract ID: 218 P04 – Treatment Response and Clinical Outcomes of Poorly Differentiated (PD) Grade 3 (G3) Gallbladder Neuroendocrine Carcinomas (NEC): A Single Institution Experience Published in 2017 Listed under P Download Corbett Abstract ID: 283 P05 – Carcinoid Heart Disease in Patients with Bronchopulmonary Carcinoid Published in 2017 Listed under P Download De Jesus Abstract ID: 275 P06 – Carcinoid Tumors of the Ovary: An Observational Cohort Study of 67 Primary and Metastatic Cases Published in 2017 Listed under P, Poster Download Feingold Abstract ID: 280 pdf Download Poster (945 KB) P07 – Association Between Duration of Somatostatin Analogs (SSAs) Use and Quality of Life in Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Published in 2017 Listed under P, Poster Download Halperin Abstract ID: 243 pdf Download Poster (354 KB) P08 – Assessment of the Association Between the Burden of Carcinoid Syndrome Symptoms and the Quality of Life Among Patients with Carcinoid Syndrome in the United States Based on the FACT-G Instrument Published in 2017 Listed under P, Poster Download Huynh Abstract ID: 245 pdf Download Poster (282 KB) P09 – International Patient Survey of Physical, Emotional, and Informational Challenges when Living with Neuroendocrine Tumors: Understanding the Unmet Needs Published in 2017 Listed under P, Poster Download Khan Abstract ID: 266 pdf Download Poster (417 KB) P10 – Somatostatin Analog Usage in Neuroendocrine Tumors: A Retrospective Database Analysis Published in 2017 Listed under P Download Klink Abstract ID: 234 P11 – Evaluation of the Impact of the Burden of Carcinoid Syndrome Symptoms on Quality of Life Among Treated Patients with Carcinoid Syndrome in the U.S. Based on the PROMIS–29 Instrument Published in 2017 Listed under P, Poster Download Neary Abstract ID: 244 pdf Download Poster (321 KB) P12 – Ovarian Metastasis from Midgut Neuroendocrine Tumors: Incidence, Clinical Implications, and Management Options—An Update Published in 2017 Listed under P Download Wang Abstract ID: 258 T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin Published in 2017 Listed under Poster, T Download Chan Abstract ID: 295 pdf Download Poster (579 KB) T02 – A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After At Least One Prior Regimen for Metastatic Disease Published in 2017 Listed under T Download Chauhan Abstract ID: 250 5 10 15 20 25 30 50 100 12»
